Industry Growth Insights published a new data on “Cell and Gene Therapy Drug Delivery Devices Market”. The research report is titled “Cell and Gene Therapy Drug Delivery Devices Market research by Types (Sterile Insulin Syringe, Pre-Filled Syringe, Infusion Bags), By Applications (Luxturna, Kymriah, Provenge, Zolgensma, Yescarta, Strimvelis), By Players/Companies Amgen, Inc., Bausch and Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio, Inc., Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), Dendreon Pharmaceuticals LLC., Helixmith Co., Ltd (ViroMed Co., Ltd), Human Stem Cell Institute, Kite Pharma, Inc., Kolon Tissue Gene, inc., Novartis AG, Orchard Therapeutics plc., Pfizer, Inc., Renova Therapeutics, Spark Therapeutics, Inc., uniQure N.V., Vericel Corporation”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cell and Gene Therapy Drug Delivery Devices Market Research Report
By Type
Sterile Insulin Syringe, Pre-Filled Syringe, Infusion Bags
By Application
Luxturna, Kymriah, Provenge, Zolgensma, Yescarta, Strimvelis
By Companies
Amgen, Inc., Bausch and Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio, Inc., Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), Dendreon Pharmaceuticals LLC., Helixmith Co., Ltd (ViroMed Co., Ltd), Human Stem Cell Institute, Kite Pharma, Inc., Kolon Tissue Gene, inc., Novartis AG, Orchard Therapeutics plc., Pfizer, Inc., Renova Therapeutics, Spark Therapeutics, Inc., uniQure N.V., Vericel Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
133
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Cell and Gene Therapy Drug Delivery Devices Market Report Segments:
The global Cell and Gene Therapy Drug Delivery Devices market is segmented on the basis of:
Types
Sterile Insulin Syringe, Pre-Filled Syringe, Infusion Bags
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Luxturna, Kymriah, Provenge, Zolgensma, Yescarta, Strimvelis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amgen, Inc.
- Bausch and Lomb Incorporated
- Becton, Dickinson and Company
- Bluebird bio, Inc.
- Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
- Dendreon Pharmaceuticals LLC.
- Helixmith Co., Ltd (ViroMed Co., Ltd)
- Human Stem Cell Institute
- Kite Pharma, Inc.
- Kolon Tissue Gene, inc.
- Novartis AG
- Orchard Therapeutics plc.
- Pfizer, Inc.
- Renova Therapeutics
- Spark Therapeutics, Inc.
- uniQure N.V.
- Vericel Corporation
Highlights of The Cell and Gene Therapy Drug Delivery Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sterile Insulin Syringe
- Pre-Filled Syringe
- Infusion Bags
- By Application:
- Luxturna
- Kymriah
- Provenge
- Zolgensma
- Yescarta
- Strimvelis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cell and Gene Therapy Drug Delivery Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cell and gene therapy drug delivery devices are medical devices that help to safely and effectively deliver medications to cells or tissues. These devices can be used in a variety of settings, including hospitals, clinics, and home health care. They may be inserted into the body through a vein or surgically placed into the tissue.
Some of the major players in the cell and gene therapy drug delivery devices market are Amgen, Inc., Bausch and Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio, Inc., Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), Dendreon Pharmaceuticals LLC., Helixmith Co., Ltd (ViroMed Co., Ltd), Human Stem Cell Institute, Kite Pharma, Inc., Kolon Tissue Gene, inc., Novartis AG, Orchard Therapeutics plc., Pfizer, Inc., Renova Therapeutics, Spark Therapeutics, Inc., uniQure N.V., Vericel Corporation.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cell and Gene Therapy Drug Delivery Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cell and Gene Therapy Drug Delivery Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cell and Gene Therapy Drug Delivery Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cell and Gene Therapy Drug Delivery Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cell and Gene Therapy Drug Delivery Devices Market Size & Forecast, 2018-2028
4.5.1 Cell and Gene Therapy Drug Delivery Devices Market Size and Y-o-Y Growth
4.5.2 Cell and Gene Therapy Drug Delivery Devices Market Absolute $ Opportunity
Chapter 5 Global Cell and Gene Therapy Drug Delivery Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Type
5.2.1 Sterile Insulin Syringe
5.2.2 Pre-Filled Syringe
5.2.3 Infusion Bags
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cell and Gene Therapy Drug Delivery Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Applications
6.2.1 Luxturna
6.2.2 Kymriah
6.2.3 Provenge
6.2.4 Zolgensma
6.2.5 Yescarta
6.2.6 Strimvelis
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cell and Gene Therapy Drug Delivery Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cell and Gene Therapy Drug Delivery Devices Analysis and Forecast
9.1 Introduction
9.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Type
9.6.1 Sterile Insulin Syringe
9.6.2 Pre-Filled Syringe
9.6.3 Infusion Bags
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Applications
9.10.1 Luxturna
9.10.2 Kymriah
9.10.3 Provenge
9.10.4 Zolgensma
9.10.5 Yescarta
9.10.6 Strimvelis
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cell and Gene Therapy Drug Delivery Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Type
10.6.1 Sterile Insulin Syringe
10.6.2 Pre-Filled Syringe
10.6.3 Infusion Bags
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Applications
10.10.1 Luxturna
10.10.2 Kymriah
10.10.3 Provenge
10.10.4 Zolgensma
10.10.5 Yescarta
10.10.6 Strimvelis
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cell and Gene Therapy Drug Delivery Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Type
11.6.1 Sterile Insulin Syringe
11.6.2 Pre-Filled Syringe
11.6.3 Infusion Bags
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Applications
11.10.1 Luxturna
11.10.2 Kymriah
11.10.3 Provenge
11.10.4 Zolgensma
11.10.5 Yescarta
11.10.6 Strimvelis
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cell and Gene Therapy Drug Delivery Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Type
12.6.1 Sterile Insulin Syringe
12.6.2 Pre-Filled Syringe
12.6.3 Infusion Bags
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Applications
12.10.1 Luxturna
12.10.2 Kymriah
12.10.3 Provenge
12.10.4 Zolgensma
12.10.5 Yescarta
12.10.6 Strimvelis
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cell and Gene Therapy Drug Delivery Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Type
13.6.1 Sterile Insulin Syringe
13.6.2 Pre-Filled Syringe
13.6.3 Infusion Bags
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cell and Gene Therapy Drug Delivery Devices Market Size Forecast by Applications
13.10.1 Luxturna
13.10.2 Kymriah
13.10.3 Provenge
13.10.4 Zolgensma
13.10.5 Yescarta
13.10.6 Strimvelis
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cell and Gene Therapy Drug Delivery Devices Market: Competitive Dashboard
14.2 Global Cell and Gene Therapy Drug Delivery Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Amgen, Inc.
14.3.2 Bausch and Lomb Incorporated
14.3.3 Becton, Dickinson and Company
14.3.4 Bluebird bio, Inc.
14.3.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
14.3.6 Dendreon Pharmaceuticals LLC.
14.3.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
14.3.8 Human Stem Cell Institute
14.3.9 Kite Pharma, Inc.
14.3.10 Kolon Tissue Gene, inc.
14.3.11 Novartis AG
14.3.12 Orchard Therapeutics plc.
14.3.13 Pfizer, Inc.
14.3.14 Renova Therapeutics
14.3.15 Spark Therapeutics, Inc.
14.3.16 uniQure N.V.
14.3.17 Vericel Corporation
